MYCB1 Group B.V. is a pharmaceutical and health technology company using Real-World Evidence in clinical and behavioural interventions with the final goal of optimizing patients’ outcomes and to deliver Health Economics Evaluations and Health Technology Assessments (HTA) to payers and regulatory decision makers.

Categorieën